These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20435259)

  • 1. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):18S-31S. PubMed ID: 20435259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):5S-17S. PubMed ID: 20435258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):52S-68S. PubMed ID: 20435262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
    Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
    J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):32S-42S. PubMed ID: 20435260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
    Conte MS
    J Vasc Surg; 2010 May; 51(5 Suppl):69S-75S. PubMed ID: 20435263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: what are its implications?
    Bradbury AW
    Semin Vasc Surg; 2009 Dec; 22(4):267-74. PubMed ID: 20006808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Raab G; Ruckley CV
    Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of combined superficial femoral endovascular revascularization and popliteal to distal bypass for patients with tissue loss.
    Lantis J; Jensen M; Benvenisty A; Mendes D; Gendics C; Todd G
    Ann Vasc Surg; 2008; 22(3):366-71. PubMed ID: 18466815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial in perspective.
    Bradbury AW;
    J Vasc Surg; 2010 May; 51(5 Suppl):1S-4S. PubMed ID: 20435257
    [No Abstract]   [Full Text] [Related]  

  • 11. A Comparison of Outcomes in Patients with Infrapopliteal Disease Randomised to Vein Bypass or Plain Balloon Angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial.
    Popplewell MA; Davies HOB; Narayanswami J; Renton M; Sharp A; Bate G; Patel S; Deeks J; Bradbury AW
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):195-201. PubMed ID: 28602580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT.
    Moakes CA; Bradbury AW; Abdali Z; Bate GR; Hall J; Jarrett H; Kelly L; Kigozi J; Lockyer S; Meecham L; Patel S; Popplewell M; Slinn G; Deeks JJ;
    Health Technol Assess; 2024 Oct; 28(65):1-72. PubMed ID: 39397484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editor's Choice - A Comparison of Clinical Outcomes Between Primary Bypass and Secondary Bypass After Failed Plain Balloon Angioplasty in the Bypass versus Angioplasty for Severe Ischaemia of the Limb (BASIL) Trial.
    Meecham L; Patel S; Bate GR; Bradbury AW
    Eur J Vasc Endovasc Surg; 2018 May; 55(5):666-671. PubMed ID: 29599067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis.
    Korhonen M; Biancari F; Söderström M; Arvela E; Halmesmäki K; Albäck A; Lepäntalo M; Venermo M
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):378-84. PubMed ID: 21195637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of femoropopliteal endovascular interventions on subsequent open bypass.
    Gifford SM; Fleming MD; Mendes BC; Stauffer KC; De Martino RR; Oderich GS; Gloviczki P; Bower TC
    J Vasc Surg; 2016 Sep; 64(3):623-8. PubMed ID: 27288105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical implications of early failed endovascular intervention of the superficial femoral artery.
    Joels CS; York JW; Kalbaugh CA; Cull DL; Langan EM; Taylor SM
    J Vasc Surg; 2008 Mar; 47(3):562-5. PubMed ID: 18295107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When to call it a day: incremental risk of amputation and death after multiple revascularization.
    Hawkins AT; Schaumeier MJ; Smith AD; Hevelone ND; Nguyen LL
    Ann Vasc Surg; 2014 Jan; 28(1):35-47. PubMed ID: 24332258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining superficial femoral artery endovascular treatment with distal vein bypass.
    Marcucci G; Accrocca F; Gabrielli R; Antonelli R; Giordano A; De Vivo G; Siani A
    J Cardiovasc Surg (Torino); 2015 Jun; 56(3):383-91. PubMed ID: 25644823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
    Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
    J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.